DHR
68
2
PPL
57
2
EOG
37
4
THC
48
2
WEC
45
2
STX
64
-5
R
67
4
ZTS
25
4
HRL
35
12
ROP
42
4
FCX
75
3
WMT
55
-4
WYNN
48
-2
PH
64
2
MCHP
58
11
AVGO
35
-19
LH
48
5
XYL
35
2
ROST
68
-3
AES
54
7
DHR
68
2
PPL
57
2
EOG
37
4
THC
48
2
WEC
45
2
STX
64
-5
R
67
4
ZTS
25
4
HRL
35
12
ROP
42
4
FCX
75
3
WMT
55
-4
WYNN
48
-2
PH
64
2
MCHP
58
11
AVGO
35
-19
LH
48
5
XYL
35
2
ROST
68
-3
AES
54
7
Financhill
Back

Adaptive Hedged Multi-AssetETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
41

AMAX
Adaptive Hedged Multi-AssetETF

Last Price:
$8.03
Seasonality Move:
0.15%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.13
Seasonality Move:
0.59%
Sell
41
Adaptive Hedged Multi-AssetETF (AMAX) is a Sell

Is Adaptive Hedged Multi-AssetETF a Buy, Sell or Hold?

  • The current Adaptive Hedged Multi-AssetETF [AMAX] share price is $8.08. The Score for AMAX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AMAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AMAX Stock Price Chart

What is Adaptive Hedged Multi-AssetETF's stock price today?

  • The Adaptive Hedged Multi-AssetETF share price today is $8.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMAX is experiencing selling pressure, which indicates risk of future bearish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AMAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 53.95 Buy
Chaikin Money Flow: -8409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.96 - 8.06) Buy
Bollinger Bands (100): (7.95 - 8.23) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

AMAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.01 Buy
20-day SMA: 8.02 Buy
50-day SMA: 8.11 Sell
200-day SMA: 7.9 Buy
8-day EMA: 8.02 Buy
20-day EMA: 8.03 Buy
50-day EMA: 8.07 Buy
200-day EMA: 7.99 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

Adaptive Hedged Multi-AssetETF Earnings Growth & AMAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Adaptive Hedged Multi-AssetETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):